Merlind Mustafov

Pharma commercial strategy, rare disease, market access and international market entry.

Open to full-time commercial & brand leadership roles, and select advisory engagements

Contact Me

About

Portrait of Merlind Mustafov

I work at the intersection of pharma commercialization, market access, and market entry. Over 15 years, I progressed from building distributor networks and launching generics across Europe, South East Europe, CIS and MENA to leading brand and customer strategy for Rare Metabolic Disease at Takeda Pharma AG.

My experience spans budget ownership, KOL engagement, patient-access initiatives, multichannel commercialization, portfolio analytics, regulatory operations and cross-functional execution.

Having worked in both generics and rare disease, I understand two very different access challenges: expanding affordable treatment at scale and helping small patient populations reach highly specialized therapies.

How I Ended Up in Pharma

How did I end up in pharma? Honestly, I did not plan it.

I spent my early twenties in hospitality: first at a hotel and congress center in Zug, then running the restaurant Almodóbar.

One of my regular guests was Themistoklis Moustakas, CEO and President of HealthWatch Swiss AG. Somewhere between serving him and talking across the table, he offered me an opportunity as an Administrative Assistant at his niche generics company.

I said yes because it was an opportunity, not because I had a five-year plan.

That one decision became a 15-year career: Business Coordinator, Operations Manager, Regional Sales Manager, Deputy Qualified Person, and eventually Brand and Customer Manager for Rare Metabolic Disease at Takeda.

It started because one person saw potential before I had the experience to prove it.

Track Record

Brand & Customer Manager, Rare Metabolic Disease — Takeda

7new rare disease patients identified, expanding a 33-patient base built over 5 years
80%fewer marketing materials, with higher clarity and campaign effectiveness
2patient-centric platforms launched (myHAE & ID+)
  • Appointed by the Global and Swiss Director to the OCE & Takeda HUB Core Team, defining governance that strengthened cross-functional execution and enabled scalable, data-driven customer engagement.

Business Analyst, Immunology / Plasma-Derived Products / Established Brands — Takeda

20%sales increase from a new access channel in 12 months
40%over-accrual surfaced through a new digital process
50%efficiency gain from consolidating four therapeutic areas into one BU
30%additional budget freed by that same consolidation
  • Identified, negotiated, and secured a new access channel (ProQura) for Immunology.
  • Built a data governance platform consolidating stakeholder, channel, revenue, and contract intelligence, pushing ASP beyond enterprise targets.
  • Identified a digital process gap (Art. 71) and integrated Smart-MIP into the process to close that gap, surfacing the over-accrual above.
  • Renegotiated external Patient Support Program service agreements, reducing operating costs while expanding service scope.
  • Led AI-based PV process automation, unlocking a first-of-its-kind influencer partnership for Swiss Immunology.

HealthWatch Swiss AG

300+batches released as Deputy Qualified Person
95%Swissmedic inspection compliance with uninterrupted supply
10+products launched across Europe, South East Europe, CIS and MENA
  • Oversaw the entire operations of HealthWatch Swiss AG and its regional subsidiaries.
  • Supported the launch of Proton Med in Serbia.
  • Led the Albania subsidiary launch from zero: legal entity, regulatory approvals, team, and go-to-market framework, reaching rapid market entry and profitability.
  • Led a commercial turnaround in Bulgaria, restructuring operations and redefining commercial strategy.
  • Negotiated strategic partnerships with Phoenix Group and Ewopharma, securing co-funded budgets and increasing promotional reach.

Portfolio Experience

Oncology

Adcetris®Ninlaro®Alunbrig®

Immunology

Takhzyro®Firazyr®Cinryze®

Plasma-Derived Therapies

Kiovig®Cuvitru®HyQvia®Advate®Adynovate®Feiba®

Rare Metabolic Disease

Replagal®Vpriv®Elaprase®Natpara®

Generics

Ferrovin®Rextol®Birmost®Brimodrop®Latidrop®Optodrop®Optodrop-Co®Lexavon®Tobraxason®Todeks®

Surgical and Vascular Medical Devices

Purple SurgicalAntemaBloodSTOP iXGore Vascular Grafts

Focus Areas

Brand & Commercial StrategyBrand planning, budgets and multichannel execution
Rare Disease & AccessMarket access, orphan drugs and patient pathways
International Market EntryDistributor networks and launch frameworks across complex markets

What I Offer

Brand & Commercial Strategy

Turn market insights into focused brand plans, measurable priorities and disciplined budget allocation.

Market Access & Patient Identification

Identify where patients are lost in the pathway and develop practical access initiatives involving HCPs, centers, payers and patient organizations.

International Market Entry

Assess markets, identify distribution partners and create practical launch and execution frameworks.

Business Analysis & Data-Led Decisions

Transform fragmented commercial data into clear reporting, forecasting and portfolio decisions.

Regulatory & Quality Grounding

Bring commercial strategy together with practical understanding of GDP, quality and compliance requirements.

Available for full-time commercial and brand leadership roles, as well as selected project-based advisory work.

References

From Reference Letters

He looks at problems from different perspectives and rapidly identifies various options for action and independently finds very good solutions. Mr. Mustafov is pro-active, resilient, efficient and reliable, and has achieved a high standard of quality.
Andrea OswaldBU Head Rare Metabolic Diseases, Takeda Pharma AG
Mr. Mustafov communicated clearly, precisely, and at the appropriate level. He made his case convincingly, presented topics in a lucid way, and used structured and objective arguments. He was perceived as a cooperative, reliable, and helpful individual who was valued by customers, colleagues, and superiors alike.
Bruno RabilierHead of BU Rare Diseases, PDT and Oncology, Takeda Pharma AG
With advanced analytical capacity and a cross-linked way of thinking, Mr. Mustafov grasps new business contexts, subject matter, and correlations readily, drawing realizable conclusions.
Pierre MorneauGeneral Manager, Takeda Pharma AG
Mr. Mustafov has shown considerable personal and professional abilities: identifying the key elements of a project, whether a product or a country, and linking them into a comprehensive action plan; rapidly familiarizing himself with the regulatory, production, and quality assurance requirements of the pharmaceutical business; and persevering with a hands-on approach even when circumstances indicated considerable difficulties. He has performed as a results-oriented manager endowed with creativity and flexibility, qualities that have led to several positive outcomes.
Aristeidis MitsopoulosVice President, RAFARM S.A. (Greek manufacturing partner to HealthWatch Swiss AG)
We knew Merlind as an extraordinarily reliable and dutiful employee who put his well-founded expertise into practice in a solution-oriented manner. Thanks to his highly independent, efficient, and goal-oriented approach, Merlind solved challenging tasks convincingly.
Themistoklis MoustakasCEO and President, HealthWatch Swiss AG

From LinkedIn Recommendations

I had the pleasure of working closely with Merlind and was consistently impressed by his professionalism and drive. He brings a strong combination of strategic thinking, business acumen, and hands-on execution, particularly in cross-functional and fast-paced environments. His collaborative nature and positive attitude make him a valued colleague and team player.
Christian SpieglOmnichannel Marketing & Digital Transformation (worked together on the same team)
I had the pleasure of working with Merlind on several Digital Health projects during his time at Takeda. Merlind stands out for his strategic mindset, strong stakeholder management, and exceptional communication skills. His ability to align cross-functional teams and drive data-driven decisions was key to our project's success.
Christian KühnHead of Sales (Associate Director), IQVIA (Merlind was Christian's client)
He's a very fast learner, sees the big picture and connects the dots, challenges the status quo in an appropriate way and strives for continuous improvement. He has an outstanding business mindset and eagerly develops into new areas of responsibilities. I recommend Merlind as a great team player, innovator and colleague!
Dr. Andreas Uttenweiler, MBADirect manager, Takeda Pharma AG
Merlind is very reliable, highly professional, planning two steps ahead, always one step faster than others!
Kenan TihicExecutive Director Business Development, TUZLAFARM doo Tuzla (client, Bosnia & Herzegovina)

Career Timeline

2004–2008
Hospitality Operations & Restaurant Management
Parkhotel Zug / Congress Center Metalli Zug / Restaurant Almodóbar
2009–2010
Administrative Assistant
HealthWatch Swiss AG
2011–2013
Business Coordinator
HealthWatch Swiss AG
2014–2016
Operations Manager & Deputy Qualified Person
HealthWatch Swiss AG
2017–2018
Regional Sales Manager & Deputy Qualified Person
HealthWatch Swiss AG
2019
Process Optimization and Digitalization
Fredi Sidler Transport AG
2020–2021
Assistant Marketing and Sales
Shire International GmbH / Takeda Pharma AG
2021–2022
Marketing Project Coordinator
Takeda Pharma AG
2022–2024
Brand and Customer Manager, Rare Metabolic Disease & Business Analyst
Takeda Pharma AG
2025–Present
Business Consultant, Car & Luxury Goods
Independent Consulting
2026–Present
Co-Founder (side project)
Templivo.com

Contact

Email: mustafovmerlind@gmail.com

Based in Switzerland and open to conversations about rare disease commercialization, generics, market access, brand strategy, business analysis and international market entry across Europe, South East Europe, CIS and MENA.